COMPANY

Jasper Therapeutics, Inc.

HQ: Redwood City, CA source

Keywords: immunology

Location: Redwood City, CA · source · Oct 7, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $132M (Form D filed Aug 5, 2026). SEC Form D 0001213900-26-085315 (Aug 5, 2026)
Evidence (1 event)
- Aug 5, 2026 · SEC Form D 0001213900-26-085315
  Name of Issuer: Jasper Therapeutics, Inc.; CIK: 1788028; Address: Redwood City, CA; Submission type: D; Filing date: 2026-08-05; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 131999611; Total Amount Sold: 131999611; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals